{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:23:20Z","timestamp":1794428600775,"version":"4.9.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ajogmf.2026.102165","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:05:18Z","timestamp":1792163118000},"page":"102165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pregnancy and offspring outcomes after prenatal stimulant or atomoxetine exposure: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-6479","authenticated-orcid":false,"given":"Rinat","family":"Komargodski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6011-7157","authenticated-orcid":false,"given":"Abeer","family":"Tillawe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-742X","authenticated-orcid":false,"given":"Maya","family":"Berlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1559-9258","authenticated-orcid":false,"given":"Ilan","family":"Matok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajogmf.2026.102165_bib0001","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1542\/peds.2014-3482","article-title":"Prevalence of attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"135","author":"Thomas","year":"2015","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.ajogmf.2026.102165_bib0002","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1037\/ccp0000217","article-title":"Girls with childhood ADHD as adults: cross-domain outcomes by diagnostic persistence","volume":"85","author":"Owens","year":"2017","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"10.1016\/j.ajogmf.2026.102165_bib0003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajog.2024.02.297","article-title":"Attention-deficit\/hyperactivity disorder in pregnancy and the postpartum period","volume":"231","author":"Scoten","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ajogmf.2026.102165_bib0004","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ogc.2018.04.010","article-title":"Management of attention deficit hyperactivity disorder during pregnancy","volume":"45","author":"Baker","year":"2018","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"5","key":"10.1016\/j.ajogmf.2026.102165_bib0005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40263-023-01005-8","article-title":"Nonstimulant medications for attention-deficit\/hyperactivity disorder (ADHD) in adults: systematic review and meta-analysis","volume":"37","author":"Radonji\u0107","year":"2023","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.ajogmf.2026.102165_bib0006","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2165\/00003088-200544060-00002","article-title":"Clinical pharmacokinetics of atomoxetine","volume":"44","author":"Sauer","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ntt.2016.01.002","article-title":"The pharmacokinetic profile of methylphenidate use in pregnancy: a study in mice","volume":"54","author":"Peters","year":"2016","journal-title":"Neurotoxicol Teratol"},{"issue":"5","key":"10.1016\/j.ajogmf.2026.102165_bib0008","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/bdrb.20168","article-title":"Developmental toxicity assessment of d,l-methylphenidate and D-methylphenidate in rats and rabbits","volume":"83","author":"Beckman","year":"2008","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"3","key":"10.1016\/j.ajogmf.2026.102165_bib0009","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/1087054718759753","article-title":"ADHD medication use during pregnancy and risk for selected birth defects: national birth defects prevention study, 1998-2011","volume":"24","author":"Anderson","year":"2020","journal-title":"J Atten Disord"},{"issue":"2","key":"10.1016\/j.ajogmf.2026.102165_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamapsychiatry.2017.3644","article-title":"Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: a cohort study from the International Pregnancy Safety Study Consortium","volume":"75","author":"Huybrechts","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"10.1016\/j.ajogmf.2026.102165_bib0011","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.43648","article-title":"Methylphenidate and atomoxetine in pregnancy and possible adverse fetal outcomes: a systematic review and meta-analysis","volume":"7","author":"Di Giacomo","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.ajogmf.2026.102165_bib0012","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1038\/s41380-025-02968-4","article-title":"In utero exposure to methylphenidate, amphetamines and atomoxetine and offspring neurodevelopmental disorders \u2013 a population-based cohort study and meta-analysis","volume":"30","author":"Bang Madsen","year":"2025","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0013","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.euroneuro.2021.01.003","article-title":"Maternal ADHD medication use during pregnancy and the risk of ADHD in children: importance of genetic predispositions and impact of using a sibling analysis","volume":"44","author":"Lemelin","year":"2021","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0014","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.ajogmf.2026.102165_bib0015","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0016","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0017","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale. Accessed June 19, 2026"},{"issue":"9","key":"10.1016\/j.ajogmf.2026.102165_bib0018","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.ajogmf.2026.102165_bib0019","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0020","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0021","unstructured":"Centers for Disease Control and Prevention. Data and statistics on birth defects. https:\/\/www.cdc.gov\/birth-defects\/data-research\/facts-stats\/index.html. Accessed August 25, 2026."},{"issue":"5","key":"10.1016\/j.ajogmf.2026.102165_bib0022","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/archpediatrics.2009.31","article-title":"The relative merits of risk ratios and odds ratios","volume":"163","author":"Cummings","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"10.1016\/j.ajogmf.2026.102165_bib0023","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.ajogmf.2026.102165_bib0024","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I 2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0025","series-title":"Comprehensive meta-analysis version 3 [computer program]","author":"Borenstein","year":"2013"},{"issue":"3","key":"10.1016\/j.ajogmf.2026.102165_bib0026","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"issue":"10","key":"10.1016\/j.ajogmf.2026.102165_bib0027","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s40264-014-0215-2","article-title":"Comparison of pregnancy and lactation labeling for attention-deficit hyperactivity disorder drugs marketed in Australia, the USA, Denmark, and the UK","volume":"37","author":"Warrer","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0028","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.reprotox.2020.03.003","article-title":"Fetal safety of methylphenidate\u2014a scoping review and meta analysis","volume":"93","author":"Koren","year":"2020","journal-title":"Reprod Toxicol"},{"issue":"9","key":"10.1016\/j.ajogmf.2026.102165_bib0029","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4088\/JCP.15m10083","article-title":"Methylphenidate in pregnancy: a multicenter, prospective, comparative, observational study","volume":"77","author":"Diav-Citrin","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.ajogmf.2026.102165_bib0030","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/AOG.0000000000002362","article-title":"Placental complications associated with psychostimulant use in pregnancy","volume":"130","author":"Cohen","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ajogmf.2026.102165_bib0031","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-0747","article-title":"Perinatal outcomes after treatment with ADHD medication during pregnancy","volume":"140","author":"N\u00f6rby","year":"2017","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ajogmf.2026.102165_bib0032","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40263-018-0505-9","article-title":"Perinatal outcomes of women diagnosed with attention-deficit\/hyperactivity disorder: an Australian population-based cohort study","volume":"32","author":"Poulton","year":"2018","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.ajogmf.2026.102165_bib0033","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.2019.20008","article-title":"First-trimester pregnancy exposure to Modafinil and risk of congenital malformations","volume":"323","author":"Damkier","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ajogmf.2026.102165_bib0034","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/1471-0528.16310","article-title":"Association of maternal attention deficit hyperactivity disorder and preterm birth: a cohort study","volume":"127","author":"Hesselman","year":"2020","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.ajogmf.2026.102165_bib0035","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13458","article-title":"Associations between ADHD medication use in pregnancy and severe malformations based on prenatal and postnatal diagnoses: a Danish registry-based study","volume":"82","author":"Kolding","year":"2021","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.ajogmf.2026.102165_bib0036","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/1087054719896857","article-title":"Amphetamine\u2013dextroamphetamine and pregnancy: neonatal outcomes after prenatal prescription mixed amphetamine exposure","volume":"25","author":"Rose","year":"2021","journal-title":"J Atten Disord"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0037","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.genhosppsych.2021.09.003","article-title":"Fifteen years\u2019 experience with methylphenidate for attention-deficit disorder during pregnancy: effects on birth weight, Apgar score and congenital malformation rates","volume":"73","author":"Damer","year":"2021","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"10.1016\/j.ajogmf.2026.102165_bib0038","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ije\/dyac180","article-title":"The association between psychostimulant use in pregnancy and adverse maternal and neonatal outcomes: results from a distributed analysis in two similar jurisdictions","volume":"52","author":"Camacho","year":"2023","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.ajogmf.2026.102165_bib0039","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/JCP.0000000000001702","article-title":"Risk of major malformations in infants after first-trimester exposure to stimulants: results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications","volume":"43","author":"Szpunar","year":"2023","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/frph.2022.1040824","article-title":"Obstetric complications in mothers with ADHD","volume":"4","author":"Walsh","year":"2022","journal-title":"Front Reprod Health"},{"issue":"4","key":"10.1016\/j.ajogmf.2026.102165_bib0041","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/s41380-023-01992-6","article-title":"In utero exposure to ADHD medication and long-term offspring outcomes","volume":"28","author":"Bang Madsen","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.ajogmf.2026.102165_bib0042","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14430","article-title":"Atomoxetine in early pregnancy and the prevalence of major congenital malformations: a multinational study","volume":"84","author":"Br\u00f6ms","year":"2023","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.ajogmf.2026.102165_bib0043","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/jamapsychiatry.2023.5073","article-title":"Prescription stimulant use during pregnancy and risk of neurodevelopmental disorders in children","volume":"81","author":"Suarez","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.ajogmf.2026.102165_bib0044","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00737-024-01450-4","article-title":"Investigating maternal and neonatal health outcomes associated with continuing or ceasing dexamphetamine treatment for women with attention-deficit hyperactivity disorder during pregnancy: a retrospective cohort study","volume":"27","author":"Russell","year":"2024","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0045","article-title":"Attention-deficit hyperactivity disorder medication use in pregnancy and risk of miscarriage","author":"Srinivas","year":"2025","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0046","article-title":"Prescription stimulant continuation in pregnancy and birth outcomes","author":"Al Hasan","year":"2025","journal-title":"J Atten Disord"},{"issue":"1","key":"10.1016\/j.ajogmf.2026.102165_bib0047","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.4088\/JCP.13m08708","article-title":"First-trimester exposure to methylphenidate: a population-based cohort study","volume":"75","author":"Pottegard","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.ajogmf.2026.102165_bib0048","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/pds.3600","article-title":"Use of ADHD medication during pregnancy from 1999 to 2010: a Danish register-based study","volume":"23","author":"H\u00e6rvig","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0049","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/CLEP.S72906","article-title":"Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy","volume":"7","author":"Bro","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.ajogmf.2026.102165_bib0050","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1097\/AOG.0000000000001108","article-title":"Committee Opinion No. 644: the Apgar score","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2026.102165_bib0051","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ajogmf.2026.102165_bib0052","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00737-025-01621-x","article-title":"Maternal and offspring outcomes associated with prescribed ADHD medication in pregnancy: a systematic review","volume":"28","author":"Tai","year":"2025","journal-title":"Arch Womens Ment Health"},{"issue":"7","key":"10.1016\/j.ajogmf.2026.102165_bib0053","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s40263-020-00728-2","article-title":"Associations of prescribed ADHD medication in pregnancy with pregnancy-related and offspring outcomes: a systematic review","volume":"34","author":"Li","year":"2020","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.ajogmf.2026.102165_bib0054","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/pds.4716","article-title":"Maternal and neonatal outcomes after exposure to ADHD medication during pregnancy: a systematic review and meta-analysis","volume":"28","author":"Jiang","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933326002648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933326002648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T19:53:49Z","timestamp":1794426829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933326002648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2589933326002648"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2026.102165","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy and offspring outcomes after prenatal stimulant or atomoxetine exposure: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2026.102165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102165"}}